NASDAQ · ACRV

Acrivon Therapeutics, Inc.

Closing price · Nov 13, 2026 $1.45

Last insider buy price $1.70 Paid by CFO Adam Levy on Jan 14, 2026 (Form 4). Not today's price.

Latest quarter · ended Jun 30, 2026

Cash got weaker

descriptionFiled Aug 12, 2026

Cash from operationsBetter

−$14.9M

Sep '24Jun '26

vs. −$16.6M a year ago

Share countDiluting

+36.2%

Sep '24Jun '26

42.85M shares vs. 31.46M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
2 funds bought, 0 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
10 real insider sales in 12 months. $41.4K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

46 funds report owning ACRV, up from 43

Holdings as of Jun 30, 2026

New7

Added17

Held14

Trimmed8

Sold out4

Last quarter

Who bought and who sold

Apr–Jun 2026

Ra Capital Management, L.P.

+47%

Sands Capital Alternatives, LLC

+8%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 13 real trades. Hidden: 16 stock grants, 14 tax withholdings. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Oct 22 Mary Miller Chief Legal Officer Open-market sale $944 513 sh at $1.84 Sold 1% of stake

Oct 5 Mary Miller Chief Legal Officer Open-market sale $585 294 sh at $1.99 Sold 1% of stake

Aug 25 Peter Blume-Jensen President and CEO, Director Open-market sale $31K 14,036 sh at $2.21 Sold 1% of stake

Aug 18 Kristina Masson EVP - Business Operations, Director Open-market sale $3.44K 1,713 sh at $2.01 Sold 1% of stake

Aug 18 Eric Devroe COO Open-market sale $1.21K 604 sh at $2.01 Sold 1% of stake

Aug 18 Erick Gamelin Chief Development Officer Open-market sale $804 400 sh at $2.01 Sold 1% of stake

Aug 18 Mary Miller Chief Legal Officer Open-market sale $372 185 sh at $2.01 Sold 1% of stake

Aug 18 Katharine Peterson Chief Accounting Officer Open-market sale $203 101 sh at $2.01 Sold 1% of stake

Aug 4 Adam Levy CFO Open-market sale $1.79K 1,142 sh at $1.57 Sold 2% of stake

Jul 21 Mary Miller Chief Legal Officer Open-market sale $1.01K 573 sh at $1.76 Sold 1% of stake

Show 3 older real trades

Jan 14 Peter Blume-Jensen President and CEO, Director Open-market buy $82.3K 49,000 sh at $1.68

Jan 14 Adam Levy CFO Open-market buy $15K 8,832 sh at $1.70

Jan 13 Eric Devroe COO Open-market buy $17.2K 10,000 sh at $1.72

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in ACRV

As of Jun 30, 2026

Fund	Owns	Value	Change
Ra Capital Management, L.P.	28.5%	$21.8M	+47%
Sands Capital Alternatives, LLC	5.3%	$4.07M	+8%
Acadian Asset Management LLC	2.7%	$2.07M	+38%
Vanguard Capital Management LLC	2.2%	$1.69M	+32%
Wellington Management Group LLP	2.1%	$1.58M	Same

"Owns" is shares reported divided by shares outstanding.